您的位置: 首页 > 农业专利 > 详情页

Tumor selective TATA -box and CAAT-box mutants
专利权人:
EpicentRx; Inc.
发明人:
Reid, Tony R.,Oronsky, Bryan T.,Hedjran, Farah,Larson, Christopher
申请号:
AU2018212017
公开号:
AU2018212017A1
申请日:
2018.01.30
申请国别(地区):
AU
年份:
2019
代理人:
摘要:
The invention provides, e.g., a recombinant virus comprising (i) a modified TATA box-based promoter, and/or (ii) a modified CAAT box-based promoter operably linked to a gene, wherein the modified TATA box- based promoter and/or modified CAAT box-based promoter lacks a functional TATA box and/or CAAT box and permit selective expression of the gene in a hyperproliferative cell. The recombinant viruses can be used to treat cell proliferative diseases and disorders, including certain forms of cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充